Evoke Pharma Inc [NASDAQ: EVOK] stock went on an upward path that rose over 162.78% on Wednesday, amounting to a one-week price increase of more than 162.78%.
Over the last 12 months, EVOK stock rose by 58.14%. The one-year Evoke Pharma Inc stock forecast points to a potential upside of 61.17. The average equity rating for EVOK stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $10.43 million, with 1.49 million shares outstanding and 1.41 million shares in the current float. Compared to the average trading volume of 15.70K shares, EVOK stock reached a trading volume of 139777399 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Evoke Pharma Inc [EVOK]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EVOK shares is $18.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EVOK stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Evoke Pharma Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 22, 2020. The new note on the price target was released on March 05, 2019, representing the official price target for Evoke Pharma Inc stock. Previously, the target price had yet another drop from $10 to $5, while B. Riley FBR Inc. kept a Buy rating on EVOK stock.
The Price to Book ratio for the last quarter was 1.79, with the Price to Cash per share for the same quarter was set at 8.46.
EVOK Stock Performance Analysis:
Evoke Pharma Inc [EVOK] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 162.78. With this latest performance, EVOK shares gained by 136.95% in over the last four-week period, additionally plugging by 50.65% over the last 6 months – not to mention a rise of 58.14% in the past year of trading.
Insight into Evoke Pharma Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Evoke Pharma Inc [EVOK] shares currently have an operating margin of -43.17% and a Gross Margin at 97.36%. Evoke Pharma Inc’s Net Margin is presently recorded at -43.80%.
Return on Equity for this stock declined to -35.23%, with Return on Assets sitting at -35.23%.
Evoke Pharma Inc [EVOK] Institutonal Ownership Details
There are presently around $16.23%, or 16.45% of EVOK stock, in the hands of institutional investors.
